Prashant Narang
Overview
Explore the profile of Prashant Narang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Narang P, Garg V, Sharma A
Discov Health Syst
. 2023 May;
2(1):17.
PMID: 37251102
Background And Purpose Of Review: Over-the-counter (OTC) medication has been an integral component of an established health care system but their easy accessibility might pose significant risks. This review has...
2.
Garg V, Narang P, Taneja R
J Int Med Res
. 2022 Mar;
50(3):3000605221086457.
PMID: 35343261
Heartburn and acid regurgitation are the typical symptoms of gastroesophageal reflux. Despite the availability of several treatment options, antacids remain the mainstay treatment for gastroesophageal reflux-related symptoms based on their...
3.
Kirtane M, Bhandari A, Narang P, Santani R
Indian J Otolaryngol Head Neck Surg
. 2019 Nov;
71(Suppl 2):1060-1068.
PMID: 31750127
Cinnarizine, is approved for nausea, vomiting, motion sickness, inner ear disorders and is considered as first-line pharmacotherapy for management of vertigo. It acts by anti-vasoconstrictor activity, reducing blood viscosity and...
4.
Sarin R, Behera D, Khanna A, Singh V, Narang P, Deepak T
Indian J Tuberc
. 2019 Jun;
66(2):279-287.
PMID: 31151497
Second-line injectables (SLIs) form an essential class of agents in the treatment of drug resistant (DR) tuberculosis (TB). However, their use is sometimes limited due to serious adverse events like...
5.
Goyal V, Kadam V, Narang P, Singh V
BMC Public Health
. 2017 Oct;
17(1):817.
PMID: 29041901
Background: Drug-resistant pulmonary tuberculosis (DR-TB) is a significant public health issue that considerably deters the ongoing TB control efforts in India. The purpose of this review was to investigate the...
6.
Gundugurti P, Nagpal R, Sheth A, Narang P, Gawande S, Singh V
Asian J Psychiatr
. 2017 Aug;
30:88-93.
PMID: 28843143
Background: Schizophrenia is associated with functional challenges for patients; relapses in schizophrenia may lead to increased treatment costs and poor quality of life. Objective: This SUSTAIN-I study was conducted to...
7.
Dureja G, Jain P, Joshi M, Saxena A, Das G, Ahdal J, et al.
Pain Manag
. 2017 Jul;
7(4):311-330.
PMID: 28699380
India has a high prevalence of chronic disorders which may be associated with persistent pain. Despite the availability of multiple treatment options, chronic pain is largely untreated and contributes to...
8.
Dureja G, Iyer R, Das G, Ahdal J, Narang P
J Pain Res
. 2017 Apr;
10:709-736.
PMID: 28435313
Despite enormous progress in the field of pain management over the recent years, pain continues to be a highly prevalent medical condition worldwide. In the developing countries, pain is often...
9.
Nga T, Phuong T, Phuong T, Phuong D, Biedenbach D, Narang P, et al.
J Glob Antimicrob Resist
. 2016 Nov;
2(4):338-339.
PMID: 27873699
No abstract available.
10.
Kalra S, Deepak M, Narang P, Singh V, Uvaraj M, Agrawal N
Diabetes Technol Ther
. 2013 Jan;
15(2):129-35.
PMID: 23289432
Background: Individual sulfonylurea agents differ in pharmacokinetic properties and clinical effects. This study aimed to describe the usage pattern, glycemic improvement, hypoglycemia, and change in body mass index (BMI) observed...